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Abstract
A single helicase amino acid substitution, NS3-T249P, has been shown to increase viremia magnitude/mortality in American
crows (AMCRs) following West Nile virus (WNV) infection. Lineage/intra-lineage geographic variants exhibit consistent
amino acid polymorphisms at this locus; however, the majority of WNV isolates associated with recent outbreaks reported
worldwide have a proline at the NS3-249 residue. In order to evaluate the impact of NS3-249 variants on avian and
mammalian virulence, multiple amino acid substitutions were engineered into a WNV infectious cDNA (NY99; NS3-249P)
and the resulting viruses inoculated into AMCRs, house sparrows (HOSPs) and mice. Differential viremia profiles were
observed between mutant viruses in the two bird species; however, the NS3-249P virus produced the highest mean peak
viral loads in both avian models. In contrast, this avian modulating virulence determinant had no effect on LD50 or the
neurovirulence phenotype in the murine model. Recombinant helicase proteins demonstrated variable helicase and ATPase
activities; however, differences did not correlate with avian or murine viremia phenotypes. These in vitro and in vivo data
indicate that avian-specific phenotypes are modulated by critical viral-host protein interactions involving the NS3-249
residue that directly influence transmission efficiency and therefore the magnitude of WNV epizootics in nature.
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Introduction
Since 1999, WNV has expanded its geographic range to include
both continents of the Western hemisphere and the Caribbean
islands, with recent WNV activity documented on every major
continent except Antarctica [1–8]. One hallmark feature associ-
ated with epizootic transmission events in North America has been
avian mortality, predominantly in corvid species such as the
American crow (AMCR; Corvus brachyrhynchos) [9–11]. Conse-
quently, WNV dead bird surveillance programs have allowed, for
the first time, a detailed molecular characterization of different
geographic isolates as WNV expanded across vast ecological
habitats in North America [12,13]. Results of these studies have
shown that WNV is genetically stable with maximum genetic
variation of 0.2% at the amino acid level among isolates made
during its trans-continental spread between 1999–2004 [13].
During this same time, WNV was responsible for large epizootics
resulting in marked declines in highly susceptible avian popula-
tions[14–17].
Previous studies have demonstrated the role of birds in the
WNV transmission cycle as a mechanism for restricting viral
genetic diversity through the effects of negative selection [18]. In
contrast, a substitution in the WNV genome (NS3-T249P),
associated with increased viremia production and mortality in
AMCRs, has been shown to be under strong positive selective
pressure, indicating that avian hosts can drive adaptive evolution
in addition to serving as an important source of purifying selection
[19]. A threonine (Thr) to proline (Pro) substitution has occurred
at this locus on at least three independent occasions between
lineage 1a WNVs, preceding human WNV outbreaks in Egypt
(1950), Romania and Russia (1996) and Israel (1997–98) (Fig. 1).
Considerable intra- and inter-lineage genetic heterogeneity has
been observed at this helicase domain locus. For instance, Kunjin
viruses (lineage 1b) have an alanine (Ala), lineage 2 WNVs are
associated with histidine (His) at this locus [20] and lineage 3 [21]
exhibit an asparagine (Asn), whereas many lineage 1 and the single
representative lineage 4 WNV strain [21,22] have a Thr at NS3-
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249 (Table 1, Fig. 1). Furthermore, a large outbreak of human
encephalitis in Greece in 2010 has been associated with a lineage 2
WNV exhibiting a His to Pro substitution at this locus [23],
demonstrating the selective importance of this site in alternative
lineage WNVs as well. Interestingly, the H249P Greek lineage 2
WNV isolate has the closest genetic identity to a 2004 lineage 2
isolate from a goshawk that has been associated with avian
virulence [24], indicating the potential selective role of avian
replication/virulence for driving evolution at this genetic position.
Furthermore, AMCRs inoculated with chimeric viruses generated
between AMCR virulent (NY99) and non-virulent (KN3829)
WNV strains [25] have demonstrated reversion at this locus from
a 249T residue to variable amino acids including an aspartic acid
mutation (249D), serving as additional evidence of the strong
selective pressures exerted at this position.
The existence of multiple natural (Ala, His, Pro, Thr and Asn)
and experimentally derived (Asp) genetic variants at the NS3-249
locus, coupled with the finding that this residue imparts higher
viremia potential in an avian host, highlight the potential for
strong selective pressures being exerted on the NS3-249 locus. The
emergence of lineage 1a and 2 WNVs incorporating a Pro residue
at this site has served to support the hypothesis that this site could
modulate the avian viremia capacity of various WNV lineage
viruses and potentially dictate the epizootic emergence of these
viruses. Recombinant viruses were generated in which five NS3-
249 amino acids (Ala, Thr, His, Asn and Asp) were interchanged
with the Pro of a lineage 1a cDNA clone and inoculated into
AMCR and house sparrows (HOSPs) in order to assess the
virulence potential in two reservoir avian species. In addition, we
evaluated the effect of this WNV NS3-249 residue on mammalian
virogenesis, by assessing the LD50 of 4 NS3-249 mutants in mice.
Previous in vitro studies have demonstrated differences in temper-
ature sensitivity among closely related WNV strains in mammalian
and avian cell lines [26]. As such, the impact of NS3-249 amino
acid substitutions on WNV growth exposed to elevated temper-
atures (37uC vs. 44uC) was also evaluated herein in an avian cell
line. The two primary functions of the NS3 helicase are to separate
viral RNA duplexes produced during viral RNA replication and to
hydrolyze ATP to catalyze this enzymatic function [27]. There-
fore, in vitro helicase bioassays and ATPase assays were performed
to compare functional activity between the WNV NS3 helicase
proteins expressing alternative NS3-249 amino acid residues.
Results
Sequence analyses
In order to assess the extent of intra- and inter-lineage
incorporation of the NS3-249 proline mutation, Bayesian
(Fig. 1a) and Maximum likelihood (Fig. 1b) phylogenies of WNV
strains from lineages 1–4 were constructed and the amino acid
identity at position NS3-249 for individual isolates color-coded on
the resulting phylogeny. In both analyses, results demonstrated the
threonine (blue) to occupy the ancestral position at basal nodes
and within this phylogeny, an NS3-249 mutation from a Thr to
Pro, Ala, His or Asn has been demonstrated on at least twelve
independent occasions. Eight of these mutations led to a NS3-
249P (red/magenta) at this position, with seven of these NS3-
T249P mutations having occurred within lineage 1a strains, and
one having occurred in a lineage 2 strain (Greece 2010)
(Fig. 2a)[23]. Such hypervariability at a particular locus was
consistent with positive selection at this site as was previously
reported [19]. To confirm this, we performed a Bayesian test to
estimate the non-synonymous to synonymous substitution rate
(dN/dS) of individual sites across all WNV lineages. Again, there
was strong evidence for positive selection acting on the NS3-249
site (dN/dS = 7.5, p,0.05). No other sites were identified in this
analysis for positive selection. The NS3-249 residue is predicted to
lie at the apex of a hydrophobic loop (Fig. 2b) and an alignment of
the WNVs utilized for the phylogenetic analyses indicate complete
conservation of the residues (aa 243–252; Fig. 2a) that form the
loop with the exception of the NS3-249. These data suggest that a
proline at NS3-249 may be adaptive in multiple WNV genetic
backgrounds.
Generation of recombinant WNVs
Recombinant viruses containing polymorphisms at the NS3-249
site were successfully generated following transfection with in vitro
transcribed ligation products. Cytopathic effects were observed in
all viral cultures within 3–4 days post-transfection. Prior to use for
in vitro and in vivo phenotypic assessments, the complete genomes of
all rescued viruses (NS3-249A, NS3-249D, NS3-249H, NS3-249P,
NS3-249T, NS3-249N) were sequenced. When compared to the
parental WN/IC-P991 virus, complete genomic sequencing of all
rescued mutants demonstrated that the only variation occurred at
the desired NS3-249 loci for each of the mutants.
WN/IC NS3-249 point mutant plaque phenotypes and
growth kinetics in a mammalian (Vero) cell line
In order to assess the impact of introducing alternative NS3-249
amino acids into the WN/IC NY99 backbone on the growth
kinetics in mammalian cells, we examined plaque morphology on
Vero cells (Fig. 3a), assessed genetic stability at the modified NS3-
249 loci (Fig. 3b), and quantified infectious virus as plaque forming
units (PFU) from Vero cell culture supernatant collected daily for 5
dpi (Fig. 3c). Mean plaque diameters ranged between 1.9 to
1.3 mm at 3 dpi; plaques that were significantly smaller than the
NS3-249P were identified for the 249A (p,0.01) and 249D
mutants (p,0.01) (Fig. 3a, legend). No mixed genetic populations
(Fig. 3b) were observed following propagation of the rescued
mutants on Vero cells. During the first 24 hours, the WN/IC
NS3-249D and NS3-249T generated titers that were at least 2-fold
lower than the NS3-249A, NS3-249H, and NS3-249P viruses (p,
0.05). There were no significant differences in mean peak viral
titers between the NS3-249A, NS3-249H, and NS3-249T mutants
when compared to the NS3-249P virus (p.0.1). In contrast, the
WN/IC NS3-249D developed a peak titer that was 5-fold lower
than the NS3-249P infectious clone (p,0.05), consistent with the
smaller observed plaque phenotype at dpi 3. All WN/IC NS3-249
mutants (NS3-249A, NS3-249D, NS3-249P, and NS3-249T)
reached peak titers at 48 hours post-inoculation (hpi) with the
exception of NS3-249H that peaked 24 hours later (72 hpi)
(Fig. 3c).
Murine neuroinvasive phenotypes of NS3-249 mutants
Three week-old CD-1 mice were challenged by intraperitoneal
inoculation with ten-fold serial dilutions of each of the NS3-249
genetic variants (NS3-249T, 249H, 249D and 249A) as well as the
parental WN/IC-P991 virus containing the Pro residue at NS3-
249. All viruses resulted in morbidity/mortality within 7–8 days
post-infection (dpi) and no significant difference (p.0.1) in the
calculated lethal dose 50% (LD50) was observed between the
parental (NS3-249P) and mutant viruses with, LD50 values
calculated between 0.3 and 0.6 plaque forming units (PFU).
LD50 values of 0.4 PFU were identified for 249P, 249T and 249A
viruses while the 249H and 249D viruses exhibited slightly lower
and higher values of 0.3 and 0.6 PFU, respectively.
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Avian viremia/ pathogenesis
The expression of various amino acid residues at the WNV
NS3-249 position produced a broad range of viremia profiles in
the AMCR model (Fig. 4a, 4b). The NS3-P249D and the NS3-
P249H substitutions in the NY99 genetic backbone resulted in
acute viremia profiles that were indistinguishable in magnitude
and duration from the WNV NS3-249P parental strain, except on
day 1 (p.0.1) (Fig. 4a). The greatest impact on WNV peripheral
virus production occurred with the introduction of the NS3-P249T
residue into the WNV NY99 backbone. This amino acid exchange
delayed the onset of detectable viremia by 48 hours, drastically
reduced the peak viral load from 9.6 log10 PFU/mL to 3.9 log10
PFU/mL (p,0.0001), and shifted the onset of the mean peak
viremia from 4 to 6 dpi (Fig. 4a). The WN/IC NS3-249T mutant
was the only virus in which inoculated birds did not develop
detectable viral loads (n = 3) during the seven-day experimental
study, but these three birds did develop WNV-specific neutralizing
antibody titers at fourteen dpi, providing evidence of infection
(data not shown). The NS3-P249A mutant exhibited a 49-fold
lower mean peak viremia compared to the NS3-249P virus
(p = 0.07), whereas AMCRs inoculated with the NS3-249A mutant
exhibited 234-fold higher mean titers than those from the
attenuated WN/IC NS3-249T virus (p,0.05). In a separate study
performed in AMCRs collected in 2012, viremia profiles from
AMCRs inoculated with the NS3-249N mutant were compared
directly to those inoculated with the wild type Pro virus. Similar to
the differences observed with the NS3-249A mutant, the NS3-
249N virus elicited a peak viremia at dpi 5 that was 10,000-fold
lower (p,0.01) than that observed with the NS3-249P virus
(Fig 4b).
Because the WN/IC NY99 prototype virus induces high
peripheral viral loads and 100% mortality when inoculated in
AMCRs, the importance of introducing alternative NS3-249
amino acid substitutions on avian survivorship was assessed
(Fig. 5a, 5b). The impact of alternative WNV NS3-249 residues
on the survivorship of AMCRs was dependent on the particular
amino acid introduced into the NY99 genetic backbone. The
NS3-P249T substitution constituted the AMCR group with the
highest percent survivorship (87%) [19] followed by the NS3-
P249A construct (25%). The high sustained viral loads observed in
AMCRs inoculated with the NS3-P249D and NS3-P249H
constructs resulted in no survivorship, but slightly delayed the
mean onset of death by 2 days when compared to the WNV NS3-
249P. AMCRs collected in 2012 inoculated with the wild type
NS3-249P virus also resulted in 100% mortality within six days of
inoculation, while the NS3-249N mutant demonstrated only 25%
mortality, concomitant with 10,000-fold lower viremia (Fig. 5b).
Modification of the WN/IC NS3-249 Pro residue to an Ala,
Asp or Thr had little effect on HOSP viremia profiles (Fig. 6a).
The WN/IC NS3-249 variants (NS3-249A, NS3-249D, NS3-
249H, and NS3-249T) did not significantly impact the mean peak
viral loads in the HOSP model compared to the NS3-249P (p.
0.5). All virus titers for Pro (wt) and Thr, Asp, His and Ala mutants
peaked in the peripheral blood on 3 dpi in the HOSP model;
however, the NS3-249T mutant developed mean peak viral titers
approximately 10-fold lower than the NS3-249P on day 3 dpi. In
contrast, the NS3-249H substitution in the WN/IC backbone
reduced the mean peak viral load by 200-fold, leading to viral
titers below the threshold to infect most Culex spp. mosquito
species. In a separate experiment, HOSPs collected in 2012 were
inoculated with the wild type Pro and Asn mutant viruses. Peak
viremias of approximately 6 log10 PFU/mL sera were observed in
both infection groups; however, the peak titer was delayed from
dpi 3 (Pro) to 5 dpi or later for the Asn mutant (Fig. 6b).
WNV complete genome and NS3 subgenomic sequence
analysis
In order to observe avian host selection pressures potentially
exerted on WNV populations containing different amino acid
residues at the NS3-249 site, viral RNA was extracted from
AMCR peripheral blood at the WNV peak viral load for each bird
and NS3 RT-PCR amplicons were generated for sequencing.
Crow sera collected at peak viral loads, determined by Vero cell
plaque assay, were subjected to viral RNA extraction and WNV
NS3 helicase RT-PCR amplicons were sequenced to assess
reversions within the helicase gene, particularly at the NS3-249
residue. The NS3-249D and NS3-249H viruses isolated from
Figure 1. Phylogenetic analyses of genomic WNV strains. (A) Phylogenetic tree of the coding region of 36 WNV strains, constructed using
Bayesian analysis (B) Maximum likelihood phylogenetic tree. Isolates are colored according to the amino acid at position 249 in NS3. Magenta = Pro;
Blue = Thr; Green = His; Orange = Ala; Black = Asn. Asterisks represent nodes supported by at least 95% posterior probability. Clades are
highlighted by WNV lineage. Pink = Lineage 1a; Orange = Lineage 1b; Yellow = Lineage 1c; Green = Lineage 2; Gray = Lineage 3; Blue = Lineage
4.
doi:10.1371/journal.pone.0100802.g001
Table 1. Genetic and geographic distribution of NS3-249 polymorphisms
WN/IC NS3-249 mutant Nucleotide identity Amino acid a Reference strains with same NS3-249 identity b Phylogenetic grouping
WN/IC-249P CCC Pro North American 1999-, Romania 1996, Russia 1998,
Egypt 1951, Greece 2010 (2)
Lineage 1a/2
WN/IC-249T ACC Thr Ethiopia 1976, Kenya 1998, Tunisia 1997, Russia 1998 (4) Lineage 1a/4
WN/IC-249A GCC Ala Morocco 1996 (1a), Kunjin 1960- (1b) Lineage 1a/1b
WN/IC-249H CAC His Uganda 1937, South Africa 1989, Hungary 2004 Lineage 2
WN/IC-249N AAC Asn Rabensberg (Czech Republic) 1997 Lineage 3
WN/IC-249D GAC Asp Reverting mutation identified with chimeric infections in
AMCRs.
NA-experimental mutation
aPro: Proline; Thr: Threonine; Ala: Alanine; His: Histidine; Asn: Asparagine; Asp: Aspartic acid.
bReference strains and respective lineage groupings that contain a particular amino acid at the NS3-249 position. See Fig. 1a-b. phylogenetic trees for a complete list of
representative isolates (numbers in parentheses represent WNV lineage).
doi:10.1371/journal.pone.0100802.t001
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Figure 2. Sequence alignment of NS3-235–282 and helicase structure. (A) Alignment of 36 WNV strains between NS3 aa positions 235–282.
The NS3-249 locus is indicated and the amino acid identities colored according to the same color scheme as depicted in panels A and B. Shaded areas
correspond to aa 235–243 and aa 256–282, and emboldened and underlined text highlight genetic differences as well as sites of compensatory
mutations (NS3-244 and NS3-259). Panel (B) Surface image depiction of the WNV helicase. Arrows depict RNA-entry site, ATP hydrolysis site and NS3-
249 (yellow). Other substitutions identified in this study (salmon) include Q244H just above Pro249 and D259E just behind Q244. The peptides
surrounding Pro249 include amino acids 256–282 (light cyan), 243–254 (dark cyan) and 235–243 (medium cyan).
doi:10.1371/journal.pone.0100802.g002
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AMCR sera at peak viral titers on 4-6 dpi did not contain any
amino acid substitutions within the helicase region sequenced. All
crows inoculated with WNV NS3-249A virus retained the alanine
amino acid residue at NS3-249 with the exception of one bird that
was found to have a viral genetic polymorphism at the NS3-249
position on 5 dpi. Consensus sequence analysis of the amplicon
generated from AMCR 1, the bird with one of the highest viremias
at 9.4 log10 PFU/mL, demonstrated a minority subpopulation
CCC codon at the amino acid codon encoding a Pro residue. This
attenuated WN/IC mutant (NS3-249A) also picked up a non-
synonymous substitution (Asp to Glu) ten amino acids downstream
at the NS3-259 residue in two infected AMCRs, AMCR-2 and
AMCR-6. Two AMCRs, AMCR-1 and AMCR-7, inoculated
with the highly attenuated WN/IC NS3-249T had viral popula-
tions with an amino acid substitution, Gln to His, at the NS3-244
residue.
Temperature Sensitivity of NS3-249 mutants
In order to assess whether the differential growth phenotypes of
the NS3-249 polymorphisms could be related to differential
capacity of the viral mutants to replicate at the higher
physiological temperatures observed in WNV-infected AMCRs,
NS3-249 mutants were grown in duck embryo fibroblast cells
(DEF) at highly permissive (37uC; Fig. 7a) and elevated
temperatures observed in febrile AMCRs (44uC; Fig. 7b) [26].
No significant differences were observed in virus production of any
of the NS3-249 mutants at 37uC, with all viruses generating $8
log10 PFU/mL of culture supernatant by 72–96 hpi (Fig. 7a). In
contrast, a range of temperature sensitivities were observed at
44uC (Fig. 7b), with the Pro virus generating the highest mean titer
of 7.4 log10 PFU/mL supernatant at dpi 3 and the Thr mutant
demonstrating the most consistently temperature sensitive pheno-
type, peaking at 6.8 log10 PFU/mL at dpi 4 (Fig. 7b). A direct
comparison of differences in the growth potential of the viral
mutants at the two temperatures demonstrated a clear range of
temperature sensitivity phenotypes (Fig. 7c). At 72 hpi, the Pro
virus demonstrated only a 20-fold reduction in titer at 44uC
compared to 37uC, while the Ala showed a 50-fold decrease and
the Thr mutant exhibited a 300-fold reduction in titer (Fig. 7c).
These differences accurately modeled the in vivo replication
phenotypes observed in AMCRs; nevertheless, the Asp mutant
was as temperature sensitive as the Thr mutant, yet demonstrated
a high AMCR replication phenotype. The NS3-249H virus
exhibited an intermediate temperature sensitive phenotype and
also replicated well in AMCRs.
Helicase activity of WNV NS3-249 point mutations
In order to determine the impact of non-conservative amino
acid substitutions at the NS3-249 residue on helicase function,
recombinant helicase protein containing NS3-249 point mutations
were assessed for their respective capacities to unwind short
double-stranded (ds) RNA (Fig. 8). At 125 nM of each WNV NS3
Figure 3. Phenotypic and genetic characterization of rescued WN/IC NS3-249 mutants. (A) WN/IC NS3-249 point mutant plaque
phenotypes in a mammalian (Vero) cell line. Plaque diameters were determined to be 1.860.3 mm (249P), 1.760.4 mm (249T), 1.460.3 mm (249A),
1.660.3 mm (249H), 1.360.2 mm (249D) and 1.960.5 mm (249N; not shown). (B) Chromatogram depicting the sequence identity of the NS3-249 loci
(genomic position 5456-5458) following generation of the recombinant viruses. (C) WN/IC NS3-249 point mutant growth profiles in a mammalian
(Vero) cell line. Cells were inoculated at an MOI of 0.1. Bars represent standard deviation from the mean.
doi:10.1371/journal.pone.0100802.g003
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protein, the helicase activity greatly varied when comparing NS3
proteins containing alternative NS3-249 point mutations. The
NS3-249 proteins containing the alanine and histidine residues
unwound .95% of the dsRNA molecules, whereas the NS3-249
proteins with the proline and threonine point mutations separated
.80% of the dsRNA strands. In contrast, the NS3-249D protein
only unwound ,33% of the dsRNA molecules showing a
debilitation in helicase activity when compared to the other
NS3-249 proteins. Although the helicase differed between the
variants, these differences did not correlate with the in vivo effects
observed in AMCRs.
ATPase activity of WNV NS3-249 point mutants
Because the WNV NS3-249 residue resides in close proximity to
the viral ATP binding domain, the efficiency of alternative
recombinant NS3-249 helicase proteins to hydrolyze ATP
molecules was assessed (Fig. 9). All WNV NS3-249 helicase
proteins demonstrated the capacity to hydrolyze ATP in a dose-
dependent manner. At 125 nM of each NS3 helicase protein, the
NS3-249 point mutant proteins, NS3-249D, NS3-249H, and NS3-
249P, maintained the greatest ATPase activity, hydrolyzing .80%
of ATP to ADP. In contrast, the NS3-249A and NS3-249T
helicase proteins exhibited reduced ATPase activity (,60%).
Discussion
The recent expansion of WNV throughout the Western
hemisphere and its re-emergence worldwide has highlighted
questions concerning the introduction of specific WNV genotypic
mutations that have enhanced avian transmission capacity leading
to larger WNV epizootics. Naı̈ve avian populations, moderately
competent vector mosquito species, and WNV phenotypic
adaptations to augment vector [28] and host competence [19]
are possible driving forces that led to the expeditious spread of
WNV across the continental U.S. in less than 5 years. Previous
studies have identified a critical genetic determinant within the
helicase domain of the NS3 protein (NS3-249) that modulates
WNV pathogenesis in the AMCRs [19,25]. Introduction of an
NS3-P249T substitution in a North American East Coast lineage
1a genotype backbone (NY99) restricted peripheral viral replica-
Figure 4. Viremia profiles of AMCRs inoculated with WN/IC
NS3-249 mutants. (A) Mean daily viremias from AMCRs (n = 8) from
Colorado inoculated with WN/IC NS3-249 point mutants (NS3-249P,
249D, 249T, 249H, and 249A); (B) Mean daily viremias from 2012
captured AMCRs (n = 4) inoculated with WN/IC NS3-249P and 249N
mutants. Bars denote standard deviations from the mean.
doi:10.1371/journal.pone.0100802.g004
Figure 5. Survivorship of AMCRs inoculated with WN/IC NS3-
249 mutants. (A) Survivorship of Colorado AMCRs (n = 8) inoculated
with WN/IC clone-derived viruses demonstrating variable amino acids at
the NS3-249 locus (249P, 249D, 249T, 249H, and 249A); (B) Survivorship
of AMCRs collected in 2012 (n = 4) inoculated with WN/IC clone-derived
viruses (NS3-249P and 249N).
doi:10.1371/journal.pone.0100802.g005
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tion and dramatically increased the survivorship in AMCRs [19].
Selection modeling coupled with the phenotypic evidence that this
site modulates avian replication provided further support that
replicative capacity in an avian host could be an instrumental
feature for the emergence of different WNV lineages. A
comprehensive study involving sequence alignments of 146
WNV NS3 proteins demonstrated this protein to be highly
conserved among WNVs with a maximum divergence of 10% at
the amino acid level. Highly conserved sequence motifs within the
NS3 helicase flank the NS3-249 position (NS3-235-243 and NS3-
256-282) and the NS3-256-282 motif comprises a portion of the
DEAD/H binding domain involved in phosphorylation of protein
kinase C (Fig. 2a) [29]. Interestingly, amino acid alignments of
WNV demonstrate that a series of hydrophobic residues (NS3-
243-254) within the NS3 helicase that are highly conserved among
WNVs, with variation being observed only at the NS3-249 residue
(Fig. 2a). The NS3-249 residue is positioned on the terminus of the
hydrophobic loop and would be in a strategic orientation for direct
interaction with alternative viral or host proteins (Fig. 2b).
Furthermore, this positioning would allow for any number of
amino acids to be present at this loci and, as such, explains the
potential for the variety of lineage-specific amino acid identities
observed at this site.
The introduction of an NS3-threonine at position 249 in the
NY99 backbone was sufficient to significantly lower viral loads and
delay the detection of circulating infectious virus by 48 hpi in the
AMCR model. The delay in the production of peripheral WNV
virus due to differential replication kinetics in early target host cells
could allow for the AMCR immune response to sufficiently control
viral spread through the activation of the innate and adaptive
Figure 6. Viremia profiles of HOSPs inoculated with WN/IC
NS3-249 mutants. (A) Mean daily viremias from HOSPs (n = 8) from
California inoculated with WN/IC NS3-249 point mutants (NS3-249P,
249D, 249T, 249H, and 249A); (B) Mean daily viremias from HOSPs (n = 4)
from Colorado inoculated with WN/IC NS3-249P and 249N mutants.
Bars denote standard deviations from the mean.
doi:10.1371/journal.pone.0100802.g006
Figure 7. Temperature sensitivity assessment in an avian (DEF)
cell line performed at 376C (A) and 446C (B). Cells were inoculated
at an MOI of 0.1 and titers determined by plaque titration on Vero cells.
(C) Depicts a compilation of the differential growth by subtracting titers
determined from growth at 37uC from those observed at 44uC.
doi:10.1371/journal.pone.0100802.g007
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immune responses [30]. This could explain the seropositive WNV
NS3-249T AMCRs that did not develop a detectable viremia, but
still stimulated a WNV-specific humoral immune response at 14
dpi. As observed in the HOSP model inoculated with the WNV
KN98 (NS3-249T) strain containing a threonine at the NS3-249
residue, the NS3-249T mutant did not produce significantly lower
mean peak viral loads when compared to the NS3-249P virus [31].
In contrast to the AMCR model, the WNV NS3-249T virus
produced high titers, detectable in all inoculated HOSPs. High
titers were observed in all HOSPs during the first 48 hrs of acute
infection but exhibited a rapid decline following peak viremia on
dpi 3. The lack of sustained infectious viral loads (.5 log10 PFU/
mL blood) in both avian models when compared to the WNV
NS3-249P could be one potential mechanism to explain why
WNV NS3-249T genotypes have not been associated with large
epizootics in endemic regions.
Mutant viruses with alternative amino acids at the NS3-249
residue that demonstrated an attenuated phenotype, NS3-249A
and NS3-249T, in the AMCR model incorporated additional
amino acid substitutions within domain I of the NS3 helicase in a
subset of birds. Both WN/IC NS3-249T mutants had amino acid
substitutions at the NS3-244 loci (NS3-Q244H). The WNV NS3-
Q244H (Fig. 2a and 2b) substitution has been documented in
another WNV isolate from France (2000)(Fig. 2a) that contains the
threonine residue at the NS3-249 position [32,33]. The introduc-
tion of a histidine could assist in stabilizing the NS3 hydrophobic
loop moiety when a threonine is present at the NS3-249 residue,
but further studies are needed to characterize the role of
stabilization of the hydrophobic domain as a function of avian
peripheral replication. When the NS3-249A residue was expressed
within the aforementioned domain (NS3-243-254)(Fig. 2a and 2b),
non-synonymous mutations were identified at the NS3-D259Q
residue in two of eight viremic AMCRs. The NS3-259D (Fig. 2a
Figure 8. Helicase activity of recombinant WNV helicase NS3-249 protein mutants. (A) Helicase activity with fixed concentration of NS3
(125 nM). Lane 1: ssRNA (heat denature dsRNA), Lane 2: dsRNA (no protein), Lane 3: NS3-249P, Lane 4: NS3-249A, Lane 5: NS3-249D, Lane 6: NS3-
249H, Lane 7: NS3-249T. (B) Percent dsRNA unwound by each NS3-249 helicase point mutants at 125 nM. (C) Helicase activity with increasing
concentrations of NS3 (125 nM, 250 nM, 500 nM and 1,000 nM).
doi:10.1371/journal.pone.0100802.g008
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and 2b) residue is part of the DEAD/H binding domain and is
highly conserved in all WNV NS3 proteins analyzed to date [29].
The location of this WNV NS3 motif within viral RNA and host
protein kinase C phosphorylation binding domains coupled with
the identification of additional non-synonymous mutations in the
attenuated WNV NS3-249 mutants (NS3-249A, NS3-249T)
during avian replication suggests this surface protein moiety
interacts with a critical host protein during acute infection in the
AMCR model.
The evaluation of helicase activity on the unwinding of short
dsRNA by alternative WNV NS3-249 helicase proteins did show
differences between the amino acid substitutions (249A, 249D,
249H, 249P, 249T), but the in vitro results did not correlate well
with the in vivo avian virulence studies. Further helicase analysis
under more relevant experimental conditions, i.e. higher more
biologically relevant temperatures [26], will be necessary to fully
address this hypothesis. The effect of WNV NS3-249 amino acid
substitutions on ATPase activity appeared to be functionally
coupled with the virulence potential observed in the AMCR
model, but not the HOSP model. These data suggest that the
NS3-249 residue could be important for viral helicase ATP
hydrolysis in one host species, but have minimal functionality in
another host species potentially due to direct interaction between
the NS3-249 residue and unknown host factors. Interestingly, the
changes in helicase activity were inversely correlated with changes
in ATPase activity. The NS3-249A mutant demonstrated the
highest levels of ATPase and the lowest helicase activity whereas
the NS3-249D mutant exhibited the most active ATPase and the
weakest helicase activities (Figs. 8 and 9).
Growth phenotype differences between AMCRs and HOSPs
were unanticipated because both birds are in the order
Passeriformes, although HOSPs were introduced intentionally into
the northeastern USA from Europe ca. 160 years ago [34].
Growth of the viral mutants at elevated temperatures in DEF cells
did demonstrate superior replication of the NS3-249P virus
compared to the other mutants with the NS3-249T mutant
demonstrating the greatest level of temperature sensitivity;
however, there was discordance between AMCR growth pheno-
types and temperature growth phenotypes for a number of the
mutants. Similar discordances were observed in HOSP growth
phenotypes with various NS3-249 mutants. This finding, coupled
with the observation (unpublished data) that HOSPs develop
hypothermia (unlike AMCRs) [26] following WNV infection
indicate the potential that growth at elevated temperature could be
a contributing factor to the observed AMCR phenotypes of the
mutants assessed.
The reverting and/or compensatory mutations introduced into
the WNV NS3 helicase, within the hydrophobic motif encom-
passing the NS3-249 residue, in NS3-249A and NS3-249T
mutants that demonstrated an attenuating phenotype in the
AMCR model suggests this loop motif is critical for development
of high levels of peripheral infectious virus. The NS3-249 helicase
Figure 9. NS3-249 point mutant ATPase kinetics during dsRNA unwinding. (A) ATPase activity with different concentration of NS3 protein.
Lane 1: no protein, with 62.5 nM of recombinant protein (lane 2, 5, 8, 11 and 14), 125 nM of protein (3, 6, 9, 12 and 15), and 250 nM of protein (lane 4,
7, 10, 13 and 16). (B) Percent ATP hydrolyzed by each NS3-249 helicase protein at concentrations of 125 nM.
doi:10.1371/journal.pone.0100802.g009
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mutants (NS3-249D, NS3-249H) that were highly virulent and
replicated to high viral titers in the AMCR model appeared to be
stable in the NY99 genetic backbone. Most of the NS3-249 point
mutants replicated well in both AMCRs and HOSPs; however, the
finding that the NS3-249T mutant was highly attenuated in
AMCRs but replicated well in HOSPs suggests that host protein
interactions with this motif could result in species-specific
replication differences. Furthermore, it is possible that alternative
NS3-249 amino acids could modulate infection, dissemination
and/or transmission in enzootic mosquito vectors or facilitate
replication in alternative avian hosts important for enzootic
maintenance. In addition, the role of alternative genetic changes
in different lineage 1 and alternative lineages that have polymor-
phisms at this locus could have significant effects on fitness in
different hosts. NS3-249 polymorphisms were observed to have
emerged on at least twelve different occasions (Fig. 1b and 2a).
Notably, eight of these were NS3-T249P emergence events in
lineage 1a backbone viruses (with one lineage 2 NS3-H249P event
in 2010), further supporting the contention that the genetic
backbone could modulate fitness expression and potentially restrict
the incorporation of genetic changes at NS3-249 for all WNV
lineages.
Previous studies identifying the evolutionary pressures on this
particular NS3-249 residue could partially explain the epizootic
potential of WNV strains that have incorporated a proline at this
position in the genome. Elevated infectious titers and the longer
duration of sustained infectious viremias across an extensive range
of bird species would allow for higher infection rates in susceptible
mosquito species and increase the potential for infection of bridge
vectors that primarily feed on mammals. Furthermore, the fact
that different amino acid residues present at the WNV NS3-249
site had no effect on mammalian virulence indicates that this
observed phenomenon is likely avian specific. Together, these
results could help to explain the rapid dissemination of North
American WNV strains throughout the Western Hemisphere and
Europe and the increase in WNV human/equine cases reported in
the last decade.
Materials and Methods
Sequence Analyses of West Nile viruses
An alignment of the coding region of 36 WNV strains (genomic
positions 97-10,399) was made using Clustal Omega [35].
jModelTest2 was used to determine the best-fit nucleotide
substitution model for the data [36,37]. Based on these results, a
GTR + I + C model was used in further analyses. A Bayesian
phylogeny was constructed using MrBayes [38], accessed through
Topaliv2.5 [39], with multiple runs of 1,000,000 generations and
50% burn-in. Maximum Likelihood analysis was performed using
PhyML [40] with 1,000 bootstraps. Bayesian tests for selection
acting on individual sites were performed using FUBAR in the
HyPhy package accessed through Datamonkey [41]. Genbank
accession numbers of sequences used: Koutango virus EU082200;
Australia 1960 Kunjin virus D00246; Australia 2011 JN887352;
Morocco 1996 AY701412; Czech Republic 1997 Rabensburg
strain AY765264; Hungary 2003 DQ118127; Russia 2007
FJ425721; Sarafend strain AY688948; South Africa 1989
EF429197; South Africa 2001 EF429198; Uganda 1937
M12294; Egypt 1951 AF260968; Greece 2010 HQ537483; India
1968 EU249803; Israel 1998 AF481864; Italy 2008 FJ483549;
Mexico 2003 AY660002; New York 1999 AF196835; Portugal
2004 AJ965628; Romania 1996 AF260969; Russia 1999
AF317203; Russia 2001 DQ411029; Spain 2007 FJ766331; China
2001 AY490240; Ethiopia 1976 AY603654; France 2000
AY268132; India 1980 DQ256376; Italy 1998 AF404757; Italy
2008 JF719065; Kenya 1998 AY262283; Morocco 2003
AY701413; Russia 1998 AY277251; Spain 2008 JF707789; Spain
2010 JF719069; Tunisia 1997 AY268133; Hungary 2004
DQ116961.
WNV infectious cDNAs and plasmids
Generation of infectious WNV NY99 constructs have been
described previously [42]. The non-synonymous amino acid point
mutations (Ala, Asp, His, Thr and Asn) were introduced into the
WN/IC NY99 backbone (CG plasmid) using site-directed
mutagenesis (Table 1) as previously described [43]. Following in
vitro ligation of the AB (59) and CG (39) plasmids, XbaI
linearization at the 39 terminus of the WNV genomic cDNA
was performed to serve as a template for run-off transcription. The
full-length genomic WNV DNA was treated with proteinase K
(New England Biolabs), extracted with phenol: chloroform:
isoamyl alcohol, and then chloroform, and precipitated with
ethanol and sodium acetate. The DNA pellets were resuspended in
20 ml of RNase-free water and viral genomic RNA was transcribed
for 2 hours at 37uC using the AmpliScribe T7 transcription kit
(Epicentre). Reactions included 6 mM m7G-(59)ppp-(59)A cap
analog (New England Biolabs), 20% of the manufacturer-
recommended concentration of ATP, and 0.5–2 mg of in vitro-
ligated pWN-AB/pWN-CG DNA, and the newly transcribed
RNA was transfected by electroporation into BHK-21 cells using a
BTW petri-pulser (Biorad) [42]. Transfected cells were incubated
at room temperature for 15 min, transfection culture was
removed, and 4.5 mL of MEM containing 5% pen-strep with
10% FBS was added. Culture medium was harvested when
cytopathic effects (CPE) were clearly evident (,60%), clarified by
centrifugation to remove cellular debris and distributed in aliquots
for storage at 280uC. Virus titers were determined by plaque
assay [25].
Genomic and partial genomic sequencing
RNA was extracted from rescued viruses, cDNA was generated
and sequencing [44] of the complete genomes of all viruses was
performed to confirm the genetic identity of all viruses utilized for
avian virulence testing. Sequencing of WNV cDNA within
plasmids, and overlapping cDNA fragments amplified from viral
RNA genomes by RT-PCR, was performed using previously
described protocols [45]. The extreme 59-terminal sequence of
each WN/IC NS3-249 mutant RNA genome was determined by
using the 59RACE (Invitrogen) method [42]. Similarly, the
extreme 39-terminal sequence was determined by employing E.
coli poly(A) polymerase to tail the RNA with poly(A), followed by
RT-PCR using virus-specific and oligo(dT) primers, as described
previously [46]. Total RNA was extracted directly from AMCR
sera at 4 or 5 dpi using Trizol LS (Invitrogen) or a viral RNA
extraction kit (Qiagen) to avoid confounding cell culture passage-
related sequence changes. RNA was reverse transcribed and PCR
amplified to generate a 900 nt amplicon using a 1-step RT-PCR
kit (Invitrogen). The primers used to reverse transcribe the cDNA
template and DNA amplicons were: forward primer- 59-
CAGGGTGAAAGGATGGATGAG-39 and reverse primer- 59-
CACCAACTTGCGACGGATTTG-39. All WNV amplicons
were sequenced using a capillary sequencer.
Murine virulence assessment
Groups of five 3 week-old CD-1 mice (Charles River) were
inoculated by intraperitoneal injection of 0.1 mL PBS suspension
of serial 10-fold dilutions of each of the WNV parental (NS3-249P)
and four WNV mutants (NS3-249T, 249A, 249H and 249D) from
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0.1 PFU to 1,000 PFU as previously described [47]. Mice were
monitored daily for signs of disease (ruffled fur, hunching or limb
paralysis). Mice demonstrating limb paralysis or restricted
movement in addition to ruffled fur were euthanized. Lethal dose
50% endpoints (LD50) were calculated using the Spearman-
Karber method.
In vitro growth profiles
Diameters of at least 6 well-defined plaques were measured on
Vero cells in 6-well plates from monolayers inoculated with each
virus (Pro, Thr, Ala, His, Asp and Ala mutants). Inoculated
monolayers were overlaid with 0.4% agarose plaque diameters
measured at dpi 3. Briefly, digital images of wells were taken at dpi
3 and plaque diameters calculated from the reference diameter of
the well. Duck embryonic fibroblast cells (DEF; ATCC, CCL-141)
and African green monkey kidney cells (Vero; ATCC, CCL-81)
were utilized to assess replicative fitness of the WN/IC NS3-249
point mutants in avian and mammalian cells in vitro. All viruses
(n = 5) were inoculated at an MOI , 0.1 onto monolayers of Vero
and DEF cells in triplicate using a 6-well plate format (Vero) or
25 cm2 flask (DEF). WN/IC point mutants were allowed to adsorb
for 1hr at 37uC, inoculum was removed, cells were washed 3X
with PBS, and 4.5 mL of DMEM (Vero) or 6 mL Eagle’s MEM
(DEF) (Invitrogen) with 5% (Vero) or 10% (DEF) FBS added to
each well/flask, respectively. For temperature sensitivity studies in
DEF cells, replicate experiments were performed at both 37uC
(control temperature) and 44uC (high temperature). Supernatant
from inoculated plates was removed (700 mL) from individual
replicate wells every 24hrs for 5 days and mixed 1:1 with DMEM
containing 20% FBS. 50 mL of supernatant was removed from
triplicate DEF flasks at 24hr intervals, diluted 1:10 in EMEM with
20% FBS and frozen at 280uC until assayed for viral titer.
Infectious viral titers in the supernatants were quantified using
standard plaque assay techniques on Vero cells.
Avian experimental studies
After hatch-year AMCRs were netted in 2005 under US Fish
and Wildlife Services and Colorado Parks and Wildlife permits
with permission of Morning Fresh Dairy (40u 38’ 51’’, 105u 11’
15’’ W) as well as the managers of the Colorado State Fisheries
Unit (40u 37’ 35’’ N, 105u 10’ 32’’ W) in Bellvue, CO, banded and
bled to determine pre-existing neutralizing antibodies against
WNV and St. Louis encephalitis viruses (SLEV) and housed at the
Colorado State University Animal Disease Laboratory in groups of
two within 1-m3 cages. Crows were fed an ad libitum mixture of dry
cat and dog food as previously described [25]. In order to control
for dose delivered as well as to control for the genetic identity of
administered recombinant viruses, viruses were administered by
subcutaneous inoculation rather than mosquito bite. One hundred
microliters (100 mL) of the diluted primary transfection culture
containing 1,500 PFU of the parental (NS3-249P) and NS3-249T,
249A, 249H and 249D mutants were administered subcutaneously
by needle on the breast region of eight AMCRs per virus. To
control for temporal variation in susceptibility of AMCRs to
WNV, the parental NS3-249P virus was also used for inoculation
of an additional group of four AMCRs collected in Colorado in
2011 along with an infection group with the lineage 3 Asn mutant
(n = 4). HOSPs were collected in Bakersfield, CA and Fort Collins,
CO using Japanese mist nets and box-baited traps. All captured
birds were banded, tested for pre-existing infections to SLEV and
WNV by PRNT, and housed in a mosquito-proof aviary prior to
in vivo experimentation. Groups of six HOSPs from Bakersfield
were inoculated with 1,500 PFU of the parental NS3-249P clone-
derived WNV and each NS3-249 point mutant (Ala, His, Asp and
Thr) on the breast/cervical region by 28 gauge needle. Similarly,
HOSPs from Ft. Collins, CO were inoculated with the Asn mutant
as well as the NS3-249P in order to control for variations in
geographic susceptibility. All HOSPs were checked twice daily for
clinical signs of infection, and fed ad libitum with a multi-seed
mixture supplemented with mealworms. AMCRs and HOSPs
from each experimental group were bled once daily by either
jugular or brachial venipuncture with a 26-gauge needled syringe
(AMCRs) and 28-gauge needled syringe (HOSPs) from 1–7 dpi
and monitored daily for signs of disease through 14 dpi. Each
0.2 mL blood sample (AMCRs) was added to 0.8 mL of BA-1
diluent (Hanks M-199 salts, 0.05 M Tris pH 7.6, 1% BSA,
0.35 g/L sodium bicarbonate, 100 U/mL penicillin, 100 mg/mL
streptomycin, 1 mg/mL Fungizone). HOSPs were also bled daily
through 7 dpi by jugular venipuncture, but 0.1 mL of whole blood
was added to 0.45 mL of diluent. Coagulation was allowed to take
place at room temperature for 30 min. The samples then were
placed on ice, centrifuged for 10 min at 4000-x g, and frozen at 2
80uC until titrated for infectious units using standard plaque assay
techniques. Birds were checked at least twice daily and any birds
displaying ataxia, incoordination or trouble feeding were eutha-
nized by intravenous phenobarbital overdose. All surviving birds
were similarly euthanized at dpi 14 in the same manner.
Viral Titrations
Infectious virus was assayed by plaque titration on Vero
monolayers using 6-well plates as described previously [25].
Plaque forming units were read at 3-4 dpi by adding a second
overlay containing 0.05% neutral red on the second dpi. Limits of
detection were calculated as 1.7 log10 PFU/mL for serum samples
and 100 PFU/mL for cell culture medium. Inocula for all viruses
were back titrated to confirm the uniformity of doses administered
to AMCRs and HOSPs and to approximate the multiplicity of
infection on Vero cells.
Construction of recombinant WNV NS3 helicase plasmids
The WNV NS3 helicase genes containing the wild type (Pro)
and 4 individual NS3-249 point mutations (Ala, Asp, His, Thr)
were amplified using PCR specific primers that contained BamHI
(WN.Hel1- 59TCGAACCTCATATGCTGAGGAAAAAACA-
GATCACT39) and NdeI (WN.Hel2-59TTTCTTGGATCCT-
TAACGTTTTCCCGAGGCGAAGTC39) restriction sites incor-
porated into the primer sequences. All PCR products were
sequentially digested using BamHI and NdeI restriction enzymes
and ligated into a pET-28 protein expression plasmid using T4
DNA ligase (New England Biolabs) by incubating for 1hr at room
temperature. Ligated plasmids were electroporated into XL-1 blue
electrocompetent cells (Stratagene), individual colonies were
selected and propagated overnight at 37uC in a bacterial shaker,
and the entire cloned viral NS3 domains were sequenced using
M13 forward and reverse primers.
Expression and purification of recombinant NS3 helicase
proteins
The N-terminal, His6-tagged, recombinant WNV NS3-249
point mutations were purified as described previously [48,49].
Cultures of E. coli strain Rosetta2 (DE3) (Novagen) transformed
with the expression plasmid were grown in 1 L of LB medium
containing 35 mg/mL chloramphenicol and 50 mg/mL kanamycin
at 37uC until OD600 = 0.5. The temperature was reduced to
24uC, expression of the recombinant protein was induced by
addition of IPTG to a final concentration of 0.4 mM, cultures
were incubated for an additional 12 h at 24uC, and cells were
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harvested by centrifugation. Cell pellets were resuspended in
30 mL lysis buffer (25 mM Na-phosphate pH 6.5, 300 mM NaCl,
20 mM imidazole, 5% glycerol), lysed by three passes through a
French Press at a pressure of 1000 MPa, and centrifuged at 27,000
x g for 30 min at 4uC. The supernatant was loaded onto a 5-mL
HiTrap chelating column (GE Healthcare) pre-equilibrated with
lysis buffer. The column was washed with 30 mL Buffer A (25 mM
Tris-HCl pH 8.0, 300 mM NaCl, 5% glycerol) containing 50 mM
imidazole. The protein was eluted with a linear gradient of 50–
300 mM imidazole in Buffer A. Fractions containing NS3
proteins, determined by 12% SDS-PAGE, were pooled and
dialyzed against Buffer A, first with and then without 2 mM
EDTA, concentrated to 10 mg/mL using Centriprep-50 (Milli-
pore), increased to 15% glycerol and stored at 220uC. The yields
for wild type and mutant proteins were reproducibly approxi-
mately 50 mg of purified protein per liter of E. coli culture.
All helicase substrates were composed of annealed complemen-
tary RNAs 59-CACCUCUCUAGAGUCGACCUGCAGG-
CAUCG-39 and 39-GUGGAGAGAUCUCAGC-59. In double-
stranded duplexes, the longer strand was 59-end labeled with
[c-32P] ATP using T4 polynucleotide kinase (PNK, New England
Biolab) according to the manufacturer’s protocol. The 10-mL
reaction mixture (3 mL water, 1 mL 10x PNK buffer, 1 mL RNA or
DNA (10 pmol), 4 mL of [c-32P] ATP] (, 12 pmol) and 1 mL
PNK enzyme) was incubated for 1 hr at 37uC and quenched by
heating for 10 min at 95uC. The labeled RNA or DNA was
purified by electrophoresis on a 10% acrylamide (30:1) gel in 1X
TBE (89 mM Tris-base, 89 mM glycine, 1 mM EDTA). Regions
of the gel containing RNA or DNA were located by autoradiog-
raphy, sliced from the gel, and incubated for 6 hr at 50uC in
400 mL elution buffer (50 mM Tris-HCl pH 7.0, 500 mM NaCl,
0.1% SDS, 10 mM EDTA) in a thermo-mixer. The gel debris was
pelleted by brief centrifugation; the supernatant was treated with
2.5 volumes of cold ethanol and stored overnight at 220uC. The
precipitated RNA was collected by centrifugation at 4uC for
30 min. The pellet was washed with 1 mL 70% ethanol, dried and
dissolved in 20 mL annealing buffer (25 mM HEPES-KOH
pH 6.5 and 50 mM NaCl). The appropriate 59-end-labeled
RNA was mixed at 1:5 molar ratio with the unlabeled shorter
complementary strand and annealed in a thermocycler: 5 min at
95uC, decreased to 60uC at a rate of 1uC/min, 30 min at 60uC,
decreased to 25uC at a rate of 1uC/min and incubated overnight
at 25uC. The radiolabeled double-stranded substrate was purified
by gel electrophoresis as described above (except the elution step
was 12 hr at 4uC). The purified duplex was adjusted to a final
concentration of 100 fmol/mL in 25 mM HEPES-KOH pH 8.0,
50 mM NaCl and stored in aliquots at 220uC.
Helicase and ATPase assays
Helicase activity was assayed by 1-hour incubation at 37uC of a
10-mL reaction mixture containing 2.5 mM ATP, 1 mM MgCl2,
10 fmol nucleic acid substrate in 25 mM HEPES pH 8.0, 2 mM
dithiothreitol, and 5% glycerol as described previously [49]. The
standard reaction was initiated by addition of enzyme at the
indicated concentration (Fig. 8c) or an equivalent volume of buffer.
The reaction was quenched by addition of EDTA to a final
concentration of 20 mM and of sodium dodecyl sulfate to a final
concentration of 0.1%. Reaction products were separated by
electrophoresis on a 15% polyacrylamide native gel and detected
using a Typhoon scanner (Molecular Devices).
ATPase activity was assayed in a final volume of 10 mL in a
reaction mix containing 50 mM Tris pH 8.0, 10 mM KCl, 1 mM
MnCl2, 1 mCi [a-
32P] ATP (3,000 Ci/mmol; Amersham) with or
without enzyme, and incubated at room temperature for 10 min.
The reaction was quenched by addition of 2.5 mL of 50 mM
EDTA. 0.5 mL of the reaction mix was spotted onto a cellulose
PEI sheet (J. T. Baker), developed for 30 min by ascending thin-
layer chromatography in 0.375 M potassium phosphate pH 3.5,
air-dried, and detected using a Typhoon scanner (Molecular
Devices).
Statistical analyses
Analyses of variance (ANOVA) was used to compare mean peak
viremia and viral titers at various time point comparisons among
NS3-249 mutant viruses for in vitro studies (Vero and DEF cell
lines) and experimentally infected bird models (AMCRs and
HOSPs). Means were compared between WNV NS3-249 mutants
using Tukey’s HSD adjustment for multiple comparisons. Plaque
diameters were compared to the NS3-249P virus by two-sided
student t-test.
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